Efficacy Analysis of Adjuvant Chemotherapy with Gemcitabine Plus Platinum or S-1 in Biliary Tract Carcinoma: A Multi-Center Retrospective Study.
Huan GaoTao TianSuoni LiYin Bin ZhangXiao FuXiao-Qiang ZhengNa LiuAi-Min JiangMengdi RenXiaoni ZhangXuan LiangZhi-Ping RuanZhimin GengYu YaoPublished in: Cancer management and research (2021)
Compared with gemcitabine plus platinum, GS regimen has a tendency to obtain longer RFS (although there is no statistically significant difference) and less toxic. GS regimen has the potential to be investigated as a standard regimen for adjuvant chemotherapy.